Abbott Laboratories (NYSE: ABT) published its earnings report for the fiscal fourth quarter on Wednesday that came in better than what analysts had anticipated. The company attributed its hawkish performance to robust demand for its COVID-19 tests amidst the pandemic that has so far infected more than 26 million people in the United States and […]
Full ArticleAbbott Laboratories beats Wall Street estimates in the fourth quarter
Invezz
0 shares
2 views
You might like
Related news coverage
McDonald’s falls shy of Wall Street estimates in the fiscal fourth quarter
Invezz
McDonald’s Corp (NYSE: MCD) said on Thursday that its earnings and revenue missed Wall Street estimates in the fiscal fourth..
Advertisement
More coverage
Johnsons & Johnson’s sales jump to £16.35 billion in fiscal Q4
Invezz
Johnson & Johnson (NYSE: JNJ) reported its financial results for the fiscal fourth quarter on Tuesday that topped Wall Street..